IHCeasy m6A Ready-To-Use IHC Kit
m6A Ready-to-use reagent kit for IHC.
Human, Mouse, Rat, N6-methyladenosine
Cat no : KHC0143
6-N-Methyladenoside, m6A, N6-methyladenosine
KHC0143 is a ready-to-use IHC kit for staining of m6A (N6-methyladenosine). The kit provides all reagents, from antigen retrieval to cover slip mounting, that require little to no diluting or handling prior to use. Simply apply the reagents to your sample slide according to the protocol and you're steps away from obtaining high-quality IHC data.
|Product name||IHCeasy m6A Ready-To-Use IHC Kit|
|Sample type||FFPE tissue|
|Primary antibody type||Mouse Monoclonal|
|Secondary antibody type||Polymer-HRP-Goat anti-Mouse|
|Reactivity||Human, Mouse, Rat, N6-methyladenosine|
|Antigen Retrieval Buffer||100 mL||50×|
|Washing Buffer||100 mL ×2||20×|
|Blocking Buffer||5 mL||RTU|
|Primary Antibody||5 mL||RTU|
|Secondary Antibody||5 mL||RTU|
|Chromogen Component A||0.2 mL||RTU|
|Chromogen Component B||4 mL||RTU|
|Signal Enhancer||5 mL||RTU|
|Counter Staining Reagent||5 mL||RTU|
|Mounting Media||5 mL||RTU|
m6A (N6-methyladenosine) is the most abundant internal modification in mammalian mRNA. This modification is installed by the m6A methyltransferases or termed "writers"such as METTL3 and METTL14, and can be reversed by demethylases that serve as "erasers" such as FTO and ALKBH5. The stability of m6A-modified mRNA is regulated by m6A reader protein YTHDFs, which recognizes m6A and reduces the stability of target transcripts. m6A modification and its regulatory proteins play critical roles in cancer pathogenesis and progression. m6A modification is also invovled in viruses life cycles, suggesting that drugs targets to m6A pathway could be used for antiviral thereapy.
|Storage Instructions||All the reagents are stored at 2-8°C. The kit is stable for 6 months from the date of receipt.|
|Synonyms||6-N-Methyladenoside, m6A, N6-methyladenosine|